CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
41.92
3.35 (8.69%)
At close: Jun 06, 2025, 3:59 PM
41.85
-0.17%
After-hours: Jun 06, 2025, 05:59 PM EDT
CRISPR Therapeutics Revenue
CRISPR Therapeutics reported an annual revenue of $35M, reflecting a -90.57% growth. For the quarter ending March 31, 2025, CRISPR Therapeutics generated $0 in revenue.
Revenue (ttm)
$35M
Revenue Growth
-90.57%
Price / Sales Ratio
94.87
Revenue / Employee
$89.06K
Employees
393
Market Cap
3.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|